N2 Biomedical this week said it appointed Heidi DeGrazia as chief financial officer.
DeGrazia will be responsible for the company’s financial organization and will work with the rest of the executive team to shape its corporate strategy, according to the company.
“I am thrilled to be joining the N2 Biomedical leadership team at such a pivotal time in the company’s history. I have spent significant time in my professional career working with growth-oriented organizations, and believe exciting opportunities lie ahead for N2,” DeGrazia said in a news release.
Prior to joining N2 Biomedical, DeGrazia held financial leadership positions at Avantor, Integra Companies and Access.
“Heidi brings a broad range of skills and experience to N2’s executive management team,” CEO Randall Sword said. “Her experience overseeing financial operations at numerous enterprises in our industry will be invaluable as N2 continues to grow and expand our geographic reach and service offering to both existing and prospective clients.”